Substandard and Falsified Medicines in Myanmar [PDF]
Background: substandard and falsified medicines (SFMs) are a threat to public health. The availability of SFMs in Myanmar was reported by the World Health Organization (WHO) in 1999, but there have been few systematic surveys on falsified medicines in ...
Naoko Yoshida +2 more
exaly +7 more sources
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance [PDF]
Approximately 10% of antimicrobials used by humans in low- and middle-income countries are estimated to be substandard or falsified. In addition to their negative impact on morbidity and mortality, they may also be important drivers of antimicrobial ...
Sean Cavany +9 more
doaj +7 more sources
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance [PDF]
The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries.
Elizabeth Pisani +5 more
doaj +5 more sources
A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives [PDF]
Simultaneous expansion of the Internet and increased globalisation of the pharmaceutical industry have meant medication can be accessed transnationally from both legal and illicit sources. This has coincided with the rise of substandard and falsified medicines (SFMs) online.
Tim Mackey +2 more
exaly +4 more sources
Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications [PDF]
Objectives: The objective of this study was to determine the identification rate of substandard and falsified medications and its association with knowledge among public.Methods: This descriptive cross-sectional study was conducted in different ...
Faris El-Dahiyat +3 more
doaj +5 more sources
Combatting substandard and falsified medicines: a view from Rwanda. [PDF]
Agnes Binagwaho and colleagues describe Rwanda's experience of pharmacovigilance for malaria and tuberculosis, and call for a global treaty and leadership by the World Health Organization to address the global manufacture and trade in substandard and falsified medicines.
Agnes Binagwaho +10 more
doaj +6 more sources
Falsified and substandard medicines trafficking: A wakeup call for the African continent
While great effort is being placed on reducing disease burdens in Africa, the circulation of falsified and substandard medicines in the continent are reversing the hard-won gains.
Yusuf Hassan Wada
exaly +5 more sources
Evaluating Low-Cost Optical Spectrometers for the Detection of Simulated Substandard and Falsified Medicines [PDF]
Distribution of substandard and falsified (SF) medicines is on the rise, and its impact on public health, particularly in low-resource countries, is becoming increasingly significant. Portable, nondestructive screening devices can support regulatory authorities in their defense against the spread of SF medicines.
Wenbo Wang +2 more
exaly +5 more sources
Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries [PDF]
Substandard and falsified (SF) medicines have emerged as a global public health issue within the last two decades especially in low- and middle-income countries (LMICs). Serious consequences of this problem include a loss of trust and increased financial
Ulrike Holzgrabe, Holzgrabe Ulrike
exaly +4 more sources
Assessing knowledge, attitudes, and practices and demand-side interventions for combating substandard and falsified medicines: a scoping review [PDF]
Background The proliferation of substandard and falsified medical products (SFM) poses a significant threat to public health globally. Despite rigorous surveillance and law enforcement efforts, risk of exposure to SFM is on the rise, notably through ...
Lubna Merchant +2 more
exaly +4 more sources

